Neos Therapeutics (NEOS) Posts Wider-than-Expected Q2 Loss

Neos Therapeutics (NASDAQ: NEOS) reported Q2 EPS of ($7.76), $3.45 worse than the analyst estimate of ($4.31). Revenue for the quarter came in at $1.48 million versus the consensus estimate of $1.7 million.

For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance